Kineta Invited to Participate at the BIO CEO & Investor Conference Seattle, WA — (February 5, 2020) Kineta, Inc., a

Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference Seattle, WA — (November 26, 2019) Kineta, Inc.,

Kineta Invited to Participate at October 2019 Investor Conferences Seattle, WA — (October 7, 2019) Kineta, Inc., a clinical stage

Kineta Invited to Participate at the H.C. Wainwright 21st Annual Global Investment Conference Seattle, WA — (August 28, 2019) Kineta,

Kineta Invited to Participate at Solebury Trout’s 9th Annual CEO Roundtable Conference Seattle, WA — (August 12, 2019) Kineta, Inc.,

Kineta Secures $1.8 Million Funding Boost from Wellcome Trust on Positive Phase 1a Clinical Study Results with LHF-535 Favorable overall

Kineta Secures NIAID Grant Worth Up to $5.8M to Evaluate LHF-535 in Arenaviruses Seattle, WA — (July 15, 2019) Kineta,

Kineta Invited to Participate at the Oppenheimer Summit for Emerging Life Sciences Conference Seattle, WA — (May 28, 2019) Kineta,

Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies Kineta Immuno-Oncology to receive $15 million